The first description of a two-photon induced photopolymerization (TPIP) is about a decade ago. Since then, researchers are trying to improve this novel Additive Manufacturing Technology MT).
As life expectancy increases with advances in medical care during the last decades, tissue engineering of bone, blood vessels, skin and other organs has gained significant interest within the scientific community.
In Free Radical Photopolymerization (FRP), the role of the photoinitiator (PI) is very important towards the overall polymerization efficiency.[1-4] A lot of studies have already been devoted to the PI reactivity.
It has been shown that photoinitiators and their decomposition fragments remaining in a UVcured coating can be easily extracted by standard solvents, suggesting that the possibility of contact with food substances is high.
In free radical photopolymerization (FRP) or in radical sensitized cationic photopolymerization such as in free radical promoted cationic photopolymerization (FRPCP) [1,2], one usually observes, under air experimental conditions, the presence of an induction period and the decrease of both the po
As a low VOC technology, UV-curing continuously finds new applications in different industrial sectors, especially in the packaging industry, where UV-printed inks have many advantages over conventional inks, especially in terms of productivity, quality and environmental attractiveness.
In comparison to radical photocuring, cationic photopolymerization can still be regarded as a niche technique, although it possesses various advantages such as a reduced shrinking behavior and the absence of inhibition by molecular oxygen.
The polymerisation process from UV lamp to polymer. Photoinitiators and the generation of radicals. The chromaphore. Mechanisms of type I and type II initiators
Coronary heart disease (CHD) is one of the leading causes of morbidity and mortality in the western hemisphere ans is caused by partial or total occlusion of a coronary artery. The treatment of this disease is typically an aorto-coronary bypass operation.
In the regulatory affairs section, you can find an overview of EU legislation relevant to UV and EB curing technology and our initiatives for the industry.